What is Kneat?
Kneat specializes in the design, development, and deployment of software solutions tailored for document and data management in strictly regulated industries. Its flagship offering, the Kneat Gx platform, serves as a configurable, commercial off-the-shelf application that streamlines validation lifecycle management and testing. By focusing on the biotechnology, pharmaceutical, and medical device manufacturing sectors, Kneat addresses the complex compliance requirements inherent in these high-stakes fields. The company's business model is further supported by a robust suite of maintenance, consulting, and training services, ensuring that clients can effectively model and manage their regulated data-intensive processes with precision and audit-ready transparency.
How much funding has Kneat raised?
Kneat has raised a total of $51M across 4 funding rounds:
Stock Offering
$12.7M
Share Placement
$2M
Stock Offering
$20M
Debt
$16.3M
Stock Issuance/Offering (2020): $12.7M, investors not publicly disclosed
Share Placement (2021): $2M, investors not publicly disclosed
Stock Issuance/Offering (2021): $20M, investors not publicly disclosed
Debt (2023): $16.3M featuring IPF Partners
Key Investors in Kneat
IPF Partners
IPF Partners is a prominent alternative financing provider focused exclusively on the healthcare sector, offering tailored debt and equity financing solutions for commercial-stage biopharma and medtech companies.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Kneat?
With the recent capital infusion, Kneat is well-positioned to accelerate its strategic roadmap, focusing on scaling its Gx platform to meet the increasing demand for digital transformation in life sciences. The company is expected to prioritize the expansion of its footprint in key international markets, particularly as regulatory bodies continue to emphasize the importance of digitized validation processes. By maintaining its focus on high-compliance environments, Kneat is likely to pursue further product enhancements that integrate advanced analytics and automated testing capabilities. This strategic direction not only reinforces its competitive advantage but also ensures that the firm remains an essential partner for global manufacturers navigating the complexities of modern regulatory landscapes.
See full Kneat company page
